Global Cannabis Wins Malta Medical Cannabiz A.I. of the Year Award

Global Cannabis Wins Malta Medical Cannabiz A.I. of the Year Award

Vancouver, British Columbia, Canada, November 5, 2019 – Global Cannabis Applications Corp. (“GCAC” or the “Company”) (CSE: APP, FSE: 2FA, OTCQB: FUAPF), a leading developer of innovative data and AI technologies for the medical cannabis industry, is pleased to announce that it has been awarded ‘A.I of the Year’ at the 2019 Malta Medical Cannabiz Awards. GCAC was nominated and shortlisted as a finalist for two categories:

  • I. of the Year 2019
  • Blockchain of the Year 2019

Representing GCAC at the annual award event was Hanan Gelbendorf, Chief Marketing Officer of GCAC, and Anastasjja Plotnikova, Chief Operating Officer of GCAC Europe.

“It is an honour to be awarded A.I. of the Year at the prestigious 2019 Malta Medical Cannbiz Awards,” said Brad Moore, CEO of GCAC. “We have spent considerable effort developing a medical cannabis data solution that includes AI, blockchain and other advanced technologies to facilitate a full data loop from growers to consumers to regulators. With so many unknowns about cannabis as a viable medical treatment, we look forward to 2020 and beyond to build and provide the largest data set of smart, accurate product -symptom treatments. Our recent joint ventures relationships with European & Israeli partners and our next steps to patent our ‘Pain to Strain’ model will provide unprecedented value to the industry and our shareholders.”


The prestigious Malta Medical Cannabiz Awards are part of the Medical Cannabiz World conference taking place on November 4 & 5, 2019 at the InterContinental, Malta. The award ceremonies take place ‪on November 3 at 19:30 at the InterContinental Hotel.


GCAC was awarded A.I. of the Year for its ‘Pain to Strain’ algorithmic intelligence-based consumer biometric feedback system. The system maps a wide range of biometric feedback and user inputs with batch by batch strain information, including active pharmaceutical ingredients pathways and growing data. It is designed to capture up to 76,000 data points for every gram of medical cannabis used by patients to determine product efficacy for symptom treatment on an averaged basis. The Paint to Strain model was built in partnership with Tel Aviv based Curve Tech. Curve Tech’s decision engine uses machine learning and predictive algorithms to build valuable insights in real-time.


The Medical Cannabiz World summit is a confluence of blockchain service providers meeting brands from the global medical cannabis industry as they create solutions to some of the barriers currently problematic for medical cannabis logistics across the globe. The inaugural edition of Medical Cannabiz World opened its doors to the high-growth medicinal cannabis sector, recently unlocked by the Maltese government’s commitment to legislation supporting this global industry.


Exhibitors included brands from across the fast-growing medcann industry, such as production, logistics, payment processing, KYC, legal, regulatory and more. These areas can benefit from a blockchain approach to everything from ‘seed to sale’. The Medical Cannabiz World summit was held during Malta Week when thousands of blockchain entrepreneurs are also on the island for the Malta AI & Blockchain Summit, also being held at the InterContinental later in November.

About Global Cannabis Applications Corp.

Global Cannabis Applications Corp. is a global leader in designing, developing, marketing and acquiring innovative data technologies for the medical cannabis industry. The Citizen Green platform is the world’s first end-to-end – from patient to regulator – medical cannabis data solution. It uses six core technologies: mobile applications, artificial intelligence, regtech, smart databases, blockchain and digital reward tokens, to qualify candidates for clinical studies. These technologies facilitate the proliferation of digital conversations by like-minded people in the medical cannabis community. Managed by digital and cannabis industry experts, GCAC is focused on viral global expansion by providing the best digital experience in the cannabis market.


For more information about the Company, please visit online at, or review its profiles and on the Canadian Securities Exchange’s website (


To schedule an interview, please contact:


Bradley Moore

Chief Executive Officer
Telephone: 514.561.9091



For more information, please contact:


Corporate Communications 

Telephone: 1.855.269.9554


Corporate Communications United States
Hayden IR
Telephone: 1.917.658.7878


Forward-Looking Information

This news release may include forward-looking information within the meaning of Canadian securities legislation, concerning the business of GCAC. Forward-looking information is based on certain key expectations and assumptions made by the management of GCAC. Although management of the Company believes that the expectations and assumptions on which such forward-looking information is based are reasonable, undue reliance should not be placed on the forward-looking information because GCAC can give no assurance that they will prove to be correct. Forward-looking statements contained in this news release are made as of the date of this news release. GCAC disclaims any intent or obligation to update publicly any forward-looking information, whether as a result of new information, future events or results or otherwise, other than as required by applicable securities laws.


The Canadian Securities Exchange has not reviewed and does not accept responsibility for the adequacy and accuracy of this information.

Related posts